To determine whether a personalized messaging intervention improves blood pressure control compared to usual care in post-PCI patients, specifically measuring the primary outcome of blood pressure levels.
Approach:
Key Findings:
The personalized messaging intervention improved blood pressure control compared to usual care (specific statistical results). Higher engagement with the app was positively associated with achieving CV risk-factor targets.
Interpretation:
The study suggests that a lightweight, personalized messaging intervention can enhance secondary prevention efforts in post-PCI patients, potentially improving health outcomes.
Limitations:
Participants could not be fully blinded due to the nature of the intervention. The study was conducted at only two sites in Korea, which may limit generalizability. Potential biases or confounding factors were not fully addressed.
Conclusion:
AnSim, a smartphone-based messaging program, effectively supports post-PCI secondary prevention by improving blood pressure control and encouraging patient engagement, with implications for enhancing clinical practice.
In a multicenter registry study, genetic diagnoses were associated with substantially lower cognitive, language, and motor scores; while birth weight, surgical timing, hospitalization burden, and caregiver education were also associated with outcomes.
As ASE convenes its 37th Scientific Sessions near Denver, the meeting will spotlight echocardiographic AI and big data, contrast-enhanced ultrasound, evolving guidelines, the Feigenbaum Lecture, and the future of the sonographer workforce.
